In previous work, it was demonstrated that NR2F2 can bind to and activate the BGN promoter and enhancer regions, promoting its expression and facilitating tumor progression and the formation of an immunosuppressive microenvironment. This evidence concerns the gene NR2F2 and neoplasm.